Evidence map›Paper›PMID 27327500›Full record

ArticleNature communications2016

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.

Y Iturria-Medina, R C Sotero, P J Toussaint, J M Mateos-Pérez, A C Evans, Alzheimer’s Disease Neuroimaging Initiative

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 740 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
740citing papers in PubMed, 5 pooled it
54.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

740 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,157 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Preclinical in-vivo cerebrovascular imaging in rodent models: Methods and applications in Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  16. Article
  17. Distinct ocular microvascular alterations in Alzheimer's disease and cerebral small vessel disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. A peripheral perspective on brain health: vascular and skeletal muscle contributions.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  19. Article
  20. Review

680 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 20 institutions in 4 countries.

Y Iturria-MedinaDepartment of Neurology &Neurosurgery, McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Quebec, Canada H3A 2B4.
R C SoteroDepartment of Radiology and Hotchkiss Brain institute, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
P J ToussaintDepartment of Neurology &Neurosurgery, McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Quebec, Canada H3A 2B4.
J M Mateos-PérezDepartment of Neurology &Neurosurgery, McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Quebec, Canada H3A 2B4.
A C EvansDepartment of Neurology &Neurosurgery, McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Quebec, Canada H3A 2B4.
Alzheimer’s Disease Neuroimaging Initiative
Mayo Clinic · USUC San Diego Health System · USWashington University in St. Louis · USIndiana University Bloomington · USBaylor College of Medicine · USBrigham and Women's Hospital · USLAC+USC Medical Center · USThe University of Texas Southwestern Medical Center · USUniversity of Pennsylvania · USNew York University · USNorthwestern University · USUCLA Health · USUniversity of California, San Francisco · USUniversity of Michigan · USJohns Hopkins University · USUniversity of Alabama at Birmingham · USUniversity of California, Davis · USUniversity of Kentucky · USUniversity of Rochester Medical Center · USAlzheimer's Association · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI GRABOWSKI, THOMAS J. · 1985 to 2019
$57.2M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRASKIE, MEREDITH NICOLE · 1985 to 2019
$41.0M
NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG005142NIA NIH HHS U01 AG024904NIA NIH HHS U24 AG021886
6 · The paper itself

Abstract

Multifactorial mechanisms underlying late-onset Alzheimer's disease (LOAD) are poorly characterized from an integrative perspective. Here spatiotemporal alterations in brain amyloid-β deposition, metabolism, vascular, functional activity at rest, structural properties, cognitive integrity and peripheral proteins levels are characterized in relation to LOAD progression. We analyse over 7,700 brain images and tens of plasma and cerebrospinal fluid biomarkers from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Through a multifactorial data-driven analysis, we obtain dynamic LOAD-abnormality indices for all biomarkers, and a tentative temporal ordering of disease progression. Imaging results suggest that intra-brain vascular dysregulation is an early pathological event during disease development. Cognitive decline is noticeable from initial LOAD stages, suggesting early memory deficit associated with the primary disease factors. High abnormality levels are also observed for specific proteins associated with the vascular system's integrity. Although still subjected to the sensitivity of the algorithms and biomarkers employed, our results might contribute to the development of preventive therapeutic interventions.

Indexed as

Image Interpretation, Computer-AssistedModels, StatisticalAgedAlzheimer DiseaseAmyloid beta-PeptidesBiomarkersBlood ProteinsBrainBrain MappingCerebrovascular CirculationCognitive DysfunctionDisease ProgressionFemaleGlucoseHumansMagnetic Resonance ImagingAmyloid beta-PeptidesBiomarkersBlood ProteinsGlucoseMAPT protein, humantau Proteins

Identifiers

PMID27327500
PMCPMC4919512
OpenAlexW2474981734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.